Tiba Biotech announces the funding of an mRNA-based universal influenza vaccine project with support from the National Institute of Allergy and Infectious Diseases (NIAID) and its Collaborative Influenza Vaccine Innovation Centers (CIVIC) initiative. This moves forward Tiba’s earlier universal influenza collaboration with Prof. Florian Krammer of the Icahn School of Medicine at Mount Sinai.

For more, see the Tiba news post.